MX372952B - Formulaciones de calcio y fosfato para inflamacion oral. - Google Patents
Formulaciones de calcio y fosfato para inflamacion oral.Info
- Publication number
- MX372952B MX372952B MX2017007741A MX2017007741A MX372952B MX 372952 B MX372952 B MX 372952B MX 2017007741 A MX2017007741 A MX 2017007741A MX 2017007741 A MX2017007741 A MX 2017007741A MX 372952 B MX372952 B MX 372952B
- Authority
- MX
- Mexico
- Prior art keywords
- calcium
- liquid
- oral inflammation
- phosphate formulations
- liquid composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462093026P | 2014-12-17 | 2014-12-17 | |
| PCT/CA2015/051327 WO2016095036A1 (en) | 2014-12-17 | 2015-12-15 | Formulations of calcium and phosphate for oral inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017007741A MX2017007741A (es) | 2018-05-02 |
| MX372952B true MX372952B (es) | 2020-04-03 |
Family
ID=56125518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017007741A MX372952B (es) | 2014-12-17 | 2015-12-15 | Formulaciones de calcio y fosfato para inflamacion oral. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11590165B2 (enExample) |
| EP (1) | EP3233092B1 (enExample) |
| JP (1) | JP6781701B2 (enExample) |
| KR (1) | KR102397070B1 (enExample) |
| CN (1) | CN107530374B (enExample) |
| AU (1) | AU2015367208B2 (enExample) |
| BR (1) | BR112017013158B1 (enExample) |
| CA (1) | CA2971224C (enExample) |
| MX (1) | MX372952B (enExample) |
| WO (1) | WO2016095036A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10765650B2 (en) * | 2016-02-03 | 2020-09-08 | Forward Science Technologies, LLC | Artificial saliva |
| US10143635B2 (en) * | 2016-02-03 | 2018-12-04 | Forward Science Technologies, LLC | Artificial saliva |
| GR1009399B (el) * | 2017-06-23 | 2018-11-15 | Χρηστος Γεωργιου Φυτας | Στοματικο διαλυμα κατα της ξηροστομιας και στοματοφαρυγγικης βλεννογονιτιδας |
| WO2023183556A2 (en) * | 2022-03-24 | 2023-09-28 | Amcyte Pharma, Inc. | Treatment for retinal disorders |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB572352A (en) * | 1944-02-26 | 1945-10-03 | Charles Somerville Dillon | Improved tooth powder or preparation |
| US4716035A (en) | 1985-05-24 | 1987-12-29 | The Procter & Gamble Company | Oral compositions and methods for treating gingivitis |
| US5540913A (en) | 1987-03-17 | 1996-07-30 | Turner; Robert E. | Formulations and uses thereof in the prevention and treatment of oral lesions |
| US5268267A (en) | 1987-08-21 | 1993-12-07 | The General Hospital Corporation | Method for diagnosing small cell carcinoma |
| US5427768A (en) | 1993-06-23 | 1995-06-27 | American Dental Association Health Foundation | Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use |
| EP0871427A1 (en) * | 1995-02-24 | 1998-10-21 | American Dental Association Health Foundation | Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use |
| CN1150880C (zh) | 1995-08-08 | 2004-05-26 | 埃纳梅隆公司 | 用于使牙齿再矿化的产品和方法 |
| US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US20050054682A1 (en) * | 1996-01-04 | 2005-03-10 | Phillips Jeffrey O. | Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same |
| US5993785A (en) * | 1996-09-18 | 1999-11-30 | Erling Johansen | Mouthwash compositions |
| US6159448A (en) * | 1996-09-27 | 2000-12-12 | Enamelon, Inc. | Products and methods for the remineralization and prevention of demineralization of teeth |
| US7838046B2 (en) * | 2001-09-26 | 2010-11-23 | Tampa Bay Research Institute | Plant extracts and uses thereof |
| CA2517005A1 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| JP4669960B2 (ja) | 2003-06-03 | 2011-04-13 | 株式会社 メドレックス | 局所麻酔薬を含有する口中用または咽頭部用製剤 |
| WO2005002592A2 (en) * | 2003-07-01 | 2005-01-13 | Ranbaxy Laboratories Limited | Stable oral compositions of azithromycin monohydrate |
| AR045068A1 (es) * | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
| WO2005076987A2 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| US8518383B2 (en) * | 2006-02-03 | 2013-08-27 | Wm. Wrigley Jr. Company | Oral care products comprising buffer systems for improved mineralization/remineralization benefits |
| RU2421207C2 (ru) * | 2006-04-05 | 2011-06-20 | КЭДБЕРИ АДАМС ЮЭсЭй ЛЛС | Оральная композиция для улучшения подповерхностной реминерализации эмали в зубах млекопитающего |
| TWI445540B (zh) * | 2007-04-20 | 2014-07-21 | Ajinomoto Kk | 抗低體溫組成物 |
| JP5166780B2 (ja) * | 2007-06-20 | 2013-03-21 | 花王株式会社 | 液体口腔用組成物 |
| WO2009012393A1 (en) * | 2007-07-18 | 2009-01-22 | The Curators Of The University Of Missouri | Pharmaceutical composition comprising a proton pump inhibitor and protein component |
| US9358242B2 (en) * | 2007-08-30 | 2016-06-07 | Prelief Inc. | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions |
| US20090130232A1 (en) | 2007-11-20 | 2009-05-21 | Mohammed Zahra | Composition and method for treatment of oral inflammation an ulceration |
| TW200934385A (en) * | 2007-12-21 | 2009-08-16 | Alcon Res Ltd | Stabilized glycerophosphate-containing surgical irrigating solution |
| WO2009105568A1 (en) * | 2008-02-20 | 2009-08-27 | The Curators Of The University Of Missouri | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
| JP2009235012A (ja) | 2008-03-28 | 2009-10-15 | Gc Corp | 口腔湿潤用組成物 |
| WO2010054494A2 (en) | 2008-11-14 | 2010-05-20 | Profimed S.R.O. | Biomimetic oral care composition |
| CN101584889B (zh) | 2009-07-10 | 2012-12-12 | 山东大学威海分校 | 一种用于治疗牙周病的外用原位成型基质 |
| US20110086108A1 (en) | 2009-10-12 | 2011-04-14 | Bartholomew Weldon | Dissolving powders that can be mixed with water and used as an oral rinse |
| JP5485677B2 (ja) | 2009-12-16 | 2014-05-07 | 花王株式会社 | 口腔用組成物 |
| WO2012021415A2 (en) * | 2010-08-07 | 2012-02-16 | Research Foundation Of State University Of New York | Oral compositions comprising a zinc compound and an anti-microbial agent |
| EP2919744B1 (en) * | 2012-11-16 | 2020-09-02 | EUSA Pharma (UK) Ltd | Effervescent tablet |
-
2015
- 2015-11-19 US US14/945,865 patent/US11590165B2/en active Active
- 2015-12-15 EP EP15868778.0A patent/EP3233092B1/en active Active
- 2015-12-15 AU AU2015367208A patent/AU2015367208B2/en active Active
- 2015-12-15 WO PCT/CA2015/051327 patent/WO2016095036A1/en not_active Ceased
- 2015-12-15 JP JP2017533337A patent/JP6781701B2/ja active Active
- 2015-12-15 MX MX2017007741A patent/MX372952B/es active IP Right Grant
- 2015-12-15 CN CN201580075768.8A patent/CN107530374B/zh active Active
- 2015-12-15 KR KR1020177019831A patent/KR102397070B1/ko active Active
- 2015-12-15 CA CA2971224A patent/CA2971224C/en active Active
- 2015-12-15 BR BR112017013158-7A patent/BR112017013158B1/pt active IP Right Grant
-
2023
- 2023-02-24 US US18/113,939 patent/US20230241102A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017013158A2 (pt) | 2018-04-10 |
| MX2017007741A (es) | 2018-05-02 |
| BR112017013158B1 (pt) | 2023-05-02 |
| KR20170105517A (ko) | 2017-09-19 |
| KR102397070B1 (ko) | 2022-05-16 |
| US20230241102A1 (en) | 2023-08-03 |
| JP6781701B2 (ja) | 2020-11-04 |
| EP3233092A4 (en) | 2018-08-01 |
| EP3233092B1 (en) | 2019-09-04 |
| US11590165B2 (en) | 2023-02-28 |
| CN107530374B (zh) | 2021-07-27 |
| US20160175356A1 (en) | 2016-06-23 |
| WO2016095036A1 (en) | 2016-06-23 |
| JP2018505862A (ja) | 2018-03-01 |
| EP3233092A1 (en) | 2017-10-25 |
| AU2015367208A1 (en) | 2017-08-03 |
| CA2971224A1 (en) | 2016-06-23 |
| AU2015367208B2 (en) | 2021-04-01 |
| CN107530374A (zh) | 2018-01-02 |
| CA2971224C (en) | 2020-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500105A1 (en) | Sulfonamides as modulators of sodium channels | |
| PH12015502615A1 (en) | Chemical compounds | |
| EP3603661A3 (en) | Rna containing composition for treatment of tumor diseases | |
| MX2015016070A (es) | Composiciones antitranspirantes. | |
| PH12018500987A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
| MX2017004618A (es) | Inhibidores de la biosintesis de sulfato de heparano para el tratamiento de enfermedades. | |
| MY176246A (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
| PH12015502368B1 (en) | Antiperspirant compositions | |
| EA201890331A1 (ru) | Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| MX372952B (es) | Formulaciones de calcio y fosfato para inflamacion oral. | |
| EA201791670A1 (ru) | Твердые композиции для ухода за полостью рта | |
| BR112017004580A2 (pt) | composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento. | |
| AR101188A1 (es) | Composiciones orales anticálculo | |
| EA032654B9 (ru) | [1,2,4]ТРИАЗОЛО[4,3-b]ПИРИДАЗИНЫ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ | |
| UA119446C2 (uk) | 1,2,4-ТРИАЗОЛО[4,3-а]ПІРИДИНОВІ СПОЛУКИ ТА ЇХ ЗАСТОСУВАННЯ ЯК ПОЗИТИВНИХ АЛОСТЕРИЧНИХ МОДУЛЯТОРІВ РЕЦЕПТОРІВ MGLUR2 | |
| MX2018001751A (es) | Dihidroquinolinonas aril-sustituidas, su preparacion y su uso como farmaceuticos. | |
| MX2017008143A (es) | Complejo de zinc fosfato para el cuidado bucal. | |
| MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
| PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
| MX377595B (es) | Estructurante de alginato de zinc sodio y método de fabricación y uso de este. | |
| MX376015B (es) | Complejo de zinc y fosfato para el cuidado bucal. | |
| BR112017008524A2 (pt) | composições antitártaro para tratamento bucal que proporcionam prevenção da cristalização | |
| PH12017501693A1 (en) | Compositions for the treatment of kidney and/or liver diseases | |
| NZ739679A (en) | Cholecalciferol sulfate salts and their use for the treatment of vitamin d deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |
Owner name: FP MARANGONI INC. |